Home » Industries » Pharmaceutical


Econ One’s expert economists have experience across a wide variety of services including antitrust, class certification, damages, financial markets and securities, intellectual property, international arbitration, labor and employment, and valuation and financial analysis.


Econ One’s resources including blogs, cases, news, and more provide a collection of materials from Econ One’s experts.


Econ One is a leading economic consulting firm with expertise in the Pharmaceutical industry. With in-depth industry knowledge, our team of economists and consultants addresses critical issues that impact the pharmaceutical industry, such as generic price competition, pay-for-delay schemes, Hatch Waxman Act claims, price-fixing, market power, and cartel behavior. We have a proven track record of assisting clients with class certification and damages in pharma cases. Additionally, our international arbitration team brings global experience to pharmaceutical-related matters.

Our economic analyses and expert testimony are invaluable in cases involving generic price competition, market manipulation, contract disputes, and more. By delivering thorough economic analyses and strategic advice, we assist clients in dealing with legal intricacies related to the pharmaceutical industry.

Expert Resources and Insights

September 20, 2018
Industries: Pharmaceutical
Services: Antitrust

Our Clients

Berger Montague

Boies Schiller Flexner

Camp Fiorante Matthews Mogerman

Gibson Dunn & Crutcher

Greenberg Traurig

Hagens Berman Sobol Shapiro


Kaplan Fox

Paul Weiss, Rifkind, Wharton & Garrison

Quinn Emanuel Urquhart & Sullivan

Susman Godfrey

White & Case